Roche Holding AG (Roche Holding AG) Forward PE Ratio

: 12.46 (As of Today)

View and export this data going back to 2002. Start your Free Trial

Roche Holding AG's Forward PE Ratio for today is 12.46.

Roche Holding AG's PE Ratio without NRI for today is 11.44.

Roche Holding AG's PE Ratio for today is 14.90.

Roche Holding AG Forward PE Ratio Historical Data

The historical data trend for Roche Holding AG's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data

Trend

2015-12

2016-12

2017-12

2018-12

2019-12

2020-12

2021-12

2022-12

2023-12

2024-04

Forward PE Ratio

17.70

14.10

15.06

13.70

15.65

14.27

18.21

13.89

12.08

12.72

Roche Holding AG Semi-Annual Data
	2015-12	2016-03	2016-06	2016-09	2016-12	2017-03	2017-06	2017-09	2017-12	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2021-12	2022-03	2022-06	2022-09	2022-12	2023-03	2023-06	2023-09	2023-12	2024-03
Forward PE Ratio	17.70	14.97	15.48	14.39	14.10	16.00	15.41	14.88	15.06	13.19	13.32	13.66	13.70	15.04	14.16	14.51	15.65	14.62	15.80	14.93	14.27	15.06	17.39	16.69	18.21	17.79	15.38	15.65	13.89	13.12	14.01	12.35	12.08	13.14

Competitive Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roche Holding AG Forward PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Forward PE Ratio falls into.

Roche Holding AG Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Roche Holding AG (OTCPK:RHHBY) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Roche Holding AG Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG (Roche Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.